Early Epcoritamab Administration Revives CAR‐T Cells in Relapsed/Refractory B‐Cell Lymphomas

ABSTRACT Background Bispecific antibodies are effective for relapsed/refractory B‐cell lymphoma patients even after CAR‐T therapy. Methods Peripheral blood CAR‐T kinetics and functional analysis in vivo were carried out pre‐ and post‐epcoritamab infusion in B‐cell lymphoma patients relapsing after C...

Cijeli opis

Bibliografski detalji

Glavni autori:	Kensuke Yanashima, Yoshiki Furukawa, Midori Ishii, Shintaro Kinoshita, Yasuharu Hamano, Naoki Watanabe, Yutaka Tsukune, Hajime Yasuda, Jun Ando, Miki Ando
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2025-06-01
Serija:	eJHaem
Online pristup:	https://doi.org/10.1002/jha2.70079
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!